Blue Cloud Softech admitted to NSE trading; Q1FY27 revenue up 42%

2 min read     Updated on 18 Aug 2026, 09:16 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Blue Cloud Softech Solutions has been admitted to NSE trading under the symbol BLUECLOUDS, achieving dual listing status alongside its existing BSE listing. The move follows strong financial performance, with Q1FY27 revenue rising 41.9% to ₹292.53 crore and EBITDA margin expanding to 20.4%. The dual listing aims to enhance liquidity and support the company's strategic expansion in AI-first solutions across India, the US, and Africa.

powered bylight_fuzz_icon
48570088

*this image is generated using AI for illustrative purposes only.

Blue Cloud Softech Solutions equity shares have been admitted to trading on the National Stock Exchange of India (NSE) Main Board effective Monday, August 17, 2026, under the symbol BLUECLOUDS. The Hyderabad-based technology company continues to be listed on the Bombay Stock Exchange (BSE), marking its dual listing status. The admission covers 92,30,81,600 equity shares under the 'permitted to trade' category for companies already listed on another recognized stock exchange.

The company qualified for NSE admission based on a market capitalization that remained above the ₹1,500 crore threshold on a six-month average basis, alongside a clean compliance record. The Board of Directors approved the listing initiative on April 30, 2026, with the application submitted in August 2026.

Financial Performance Overview

Blue Cloud Softech reported accelerated growth in its recent financial disclosures. For the full fiscal year FY26, the company logged consolidated revenue of ₹1,002 crore, representing a 26% increase year-on-year. Profit after tax (PAT) rose 37% to ₹60.50 crore, while earnings before interest, taxes, depreciation, and amortization (EBITDA) surged 78% to ₹126.13 crore.

Momentum continued into the first quarter of FY27. Revenue climbed 41.9% year-on-year to ₹292.53 crore. More significantly, EBITDA nearly tripled to ₹59.61 crore, driving the EBITDA margin up to 20.4% from 10.4% in the corresponding period last year. PAT for Q1FY27 stood at ₹17.95 crore, up 24.7% year-on-year.

Metric FY26 Consolidated Q1FY27 Consolidated
Revenue ₹1,002 crore (+26%) ₹292.53 crore (+41.9%)
EBITDA ₹126.13 crore (+78%) ₹59.61 crore
EBITDA Margin 12.6% 20.4%
PAT ₹60.50 crore (+37%) ₹17.95 crore (+24.7%)
EPS ₹1.13 ₹0.23

What the Numbers Show

The divergence between revenue growth and profitability metrics highlights operational leverage in Blue Cloud Softech’s business model. While Q1FY27 revenue grew by approximately 42%, EBITDA expanded at more than double that rate, resulting in an EBITDA margin expansion of 10 percentage points compared to the prior year period. This suggests that the company's platform and intellectual property-led businesses are scaling efficiently, contributing disproportionately to profits relative to top-line growth.

Strategic Expansion and Leadership Commentary

The dual listing aims to deepen liquidity and broaden the shareholder base, including institutional investors and foreign portfolio investors. Management stated this capital market foundation supports expansion across public safety, healthcare, and digital infrastructure verticals in India, the United States, and Africa.

Key strategic initiatives include partnerships with GCIB Global for digital infrastructure projects in Ghana, Liberia, and Senegal. Notable opportunities include a US$250 million network modernization project in Ghana under negotiation and AI-enabled mining surveillance projects in Liberia.

Janaki Yarlagadda, Chairman, noted that the listing reflects the maturity of the institution since its BSE debut in 2016. Tejesh Kumar Kodali, Group Chairman, emphasized that sovereign AI platforms address real problems in public safety and healthcare, positioning the company for global scale. Vinod Babu Bollikonda, Managing Director and Group CEO, highlighted that the financial results demonstrate the scaling of IP-led businesses as government and enterprise customers deploy these solutions.

Historical Stock Returns for Blue Cloud Softech Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+0.78%+0.78%+0.78%+0.78%+0.78%+0.78%

How might the successful execution of the US$250 million Ghana network modernization project impact Blue Cloud Softech's revenue mix and geographic diversification in FY27?

What specific operational efficiencies or cost-saving measures are driving the significant expansion of EBITDA margins from 10.4% to 20.4%, and are these margins sustainable as the company scales?

To what extent will the dual listing on the NSE attract institutional and foreign portfolio investors, and how might this influence future capital allocation strategies for international expansion?

Blue Cloud Softech Solutions
View Company Insights
View All News
like16
dislike

Blue Cloud Softech to consider US healthcare acquisition and fund raise

1 min read     Updated on 17 Aug 2026, 12:25 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Blue Cloud Softech Solutions Ltd announced a board meeting on August 24, 2026, to evaluate acquiring a US healthcare firm with operations in AI-enabled solutions, home care, and clinical services. The agenda includes approving the deal structure and raising capital via preferential equity issuance or share swaps. The move requires regulatory approvals and shareholder consent, with the trading window currently closed for insiders.

powered bylight_fuzz_icon
48495325

*this image is generated using AI for illustrative purposes only.

Blue Cloud Softech Solutions will hold a meeting of its Board of Directors on Monday, August 24, 2026, at 4:30 pm to consider the proposed acquisition of equity share capital in a United States-based entity engaged in the healthcare sector. The company also plans to approve the transaction structure and raise funds through a preferential issue of equity shares or other eligible securities.

The target entity operates across multiple segments, including AI technology-enabled healthcare solutions, home care services, clinical care services, travel care services, post-acute care services, correctional healthcare support, US school education support services, and mental healthcare services. The acquisition is subject to satisfactory completion of due diligence, valuation, negotiation, and other terms as determined by the Board.

Transaction Details

The Board will consider and approve the proposed transaction structure, consideration, and commercial terms for the acquisition. This approval is contingent upon applicable regulatory approvals and the execution of definitive agreements. The company intends to raise funds for the deal by issuing equity shares and/or other eligible securities on a preferential basis. This may include a share swap as consideration for the acquisition, in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013. Final approval from members and other regulatory bodies is required.

The Board will also approve the appointment of legal, financial, tax, technical, and other professional advisors, including a SEBI-registered merchant banker and a registered valuer, to facilitate the acquisition and security issuance. The Whole Time Director and/or Company Secretary will be authorized to conduct due diligence, negotiate terms, and execute definitive documents subject to further Board approval.

Regulatory Compliance

Pursuant to Regulation 29(1)(d) read with Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company issued the intimation on August 17, 2026. The trading window for dealing in the company's securities has been closed for all designated persons and their immediate relatives since August 17, 2026. It will remain closed until 48 hours after the outcome of the Board meeting is disclosed to the Stock Exchange. Further disclosures under Regulation 30 of the SEBI LODR Regulations will be made at the appropriate stage.

Historical Stock Returns for Blue Cloud Softech Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+0.78%+0.78%+0.78%+0.78%+0.78%+0.78%

How might the proposed preferential issue of equity shares impact Blue Cloud Softech's current share price and existing shareholder dilution?

What specific regulatory hurdles could arise from cross-border acquisition approvals between India and the United States in the healthcare sector?

How does the integration of AI-enabled healthcare solutions align with Blue Cloud Softech's core software capabilities, and what synergies are expected?

Blue Cloud Softech Solutions
View Company Insights
View All News
like19
dislike

More News on Blue Cloud Softech Solutions

Must Read Next

Stocks

Denta Water to provide 6 tanks from Tungabhadra River for Mukkumpi Lift Irrigation Project 34 mins ago
no imag found
Coal India plans to bid for additional iron-ore blocks for pelletization plant 52 mins ago
Star Health Insurance anticipates home health care program to grow over 50% within a year 52 mins ago
1 Year Returns:+0.78%